This book addresses questions of ethics, socio-political policies and regulatory aspects of novel Nanomedicine-based products which are currently under development for the diagnosis and treatment of different types of diseases. It is divided in two parts. Part I is composed of the first 3 chapters, which focus on the ?fundamentals? of legal aspects, emerging threats, advantages and disadvantages of patenting Nanomedicines, whereas part II collects 12 chapters discussing different types of Nanomedicine-based products, their potential marketing aspects and patent protection. Whenever applied, each chapter offers a list of patents, based on a specific application in drug delivery and targeting.